<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03627780</url>
  </required_header>
  <id_info>
    <org_study_id>NP1127/2017</org_study_id>
    <nct_id>NCT03627780</nct_id>
  </id_info>
  <brief_title>Genetic Polymorphism and Post Operative Nausea and Vomiting (PONV)</brief_title>
  <acronym>ponv</acronym>
  <official_title>Genetic Polymorphism Associated With the Occurrence of Postoperative Vomiting and Vomiting (PONV) in Patients Undergoing Oncological Surgeries</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto do Cancer do Estado de São Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fundação de Amparo à Pesquisa do Estado de São Paulo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Instituto do Cancer do Estado de São Paulo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Nausea and vomiting affects 25-30% of individuals in the post-operative period and can reach
      more than 70-80% in high-risk patients. inherited factors may play a significant role in
      individual susceptibility and clinical research on hereditary factors involved in the
      pathogenesis of Postoperative nausea and vomiting (PONV) and chemotherapy nausea and vomiting
      (CINV) is relatively new. The aim of this study is to investigate whether inter-individual
      differences related to PONV are associated with genetic factors. 300 patients will be
      evaluated in postoperative oncological surgeries. The peripheral leukocyte DNA will be
      extracted by the Salting Out Procedure method and processed to genotyping for 48 SNPs from 15
      candidate genes by real-time PCR by the Taqman method. The possible associations with
      demographic data and factors related to surgery will be analyzed by univariate and
      multivariate analysis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study is to investigate whether inter-individual differences related to PONV
      are associated with genetic factors. 300 patients will be evaluated in postoperative
      oncological surgeries. The peripheral leukocyte DNA will be extracted by the Salting Out
      Procedure method and processed to genotyping for 48 single nucleotide polymorphisms (SNPs)
      from 15 candidate genes by real-time PCR by the Taqman method. The possible associations with
      demographic data and factors related to surgery will be analyzed by univariate and
      multivariate analysis.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 2, 2017</start_date>
  <completion_date type="Anticipated">June 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">June 2, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Polymorphism associated to PONV</measure>
    <time_frame>24 hours</time_frame>
    <description>Genetic polymorphism of candidate genes associated to PONV or noPONV</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Genetic Predisposition to Disease</condition>
  <condition>Postoperative Nausea</condition>
  <condition>Polymorphism, Genetic</condition>
  <arm_group>
    <arm_group_label>PONV</arm_group_label>
    <description>Patients presenting with postoperative nausea and vomiting</description>
  </arm_group>
  <arm_group>
    <arm_group_label>no PONV</arm_group_label>
    <description>Patients not presenting with postoperative nausea and vomiting</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>DNA extraction</intervention_name>
    <description>DNA will be extracted from white cells</description>
    <arm_group_label>PONV</arm_group_label>
    <arm_group_label>no PONV</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        300 Patients submitted to cancer surgery, classified as high-risk for PONV according to
        Apfel Score, 150 cases and 150 controls.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  High-risk patients for PONV

        Exclusion Criteria:

          -  Low risk patients for PONV
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Angela M Sousa, phd</last_name>
    <role>Principal Investigator</role>
    <affiliation>Instituto do Cancer do Estado de São Paulo</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Angela Sousa</last_name>
    <phone>5511985588339</phone>
    <email>angela.sousa@hc.fm.usp.br</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>ALEXANDRE SLULLITEL</last_name>
    <phone>5511981057525</phone>
    <email>alexandre.slullitel@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cancer Institute of the State of Sao Paulo - ICESP</name>
      <address>
        <city>Sao Paulo</city>
        <state>São Paulo</state>
        <zip>01403010</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>angela sousa, phD</last_name>
      <phone>3893-2000</phone>
      <phone_ext>6680</phone_ext>
      <email>angela.sousa@icesp.org.br</email>
    </contact>
    <investigator>
      <last_name>Leonardo oooooo, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>angela m sousa, phD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>hazem a ashmawi, phD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cancer Institute of the State of Sao Paulo</name>
      <address>
        <city>Sao Paulo</city>
        <state>São Paulo</state>
        <zip>01403010</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>angela sousa, PhD</last_name>
      <phone>2661</phone>
      <phone_ext>6680</phone_ext>
      <email>angela.sousa@hc.fm.usp.br</email>
    </contact>
    <investigator>
      <last_name>angela m sousa, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>alexandre slullitel, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Roger Chammas, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <results_reference>
    <citation>Hayase T, Sugino S, Moriya H, Yamakage M. TACR1 gene polymorphism and sex differences in postoperative nausea and vomiting. Anaesthesia. 2015 Oct;70(10):1148-59. doi: 10.1111/anae.13082. Epub 2015 May 27.</citation>
    <PMID>26012530</PMID>
  </results_reference>
  <results_reference>
    <citation>Wesmiller SW, Bender CM, Sereika SM, Ahrendt G, Bonaventura M, Bovbjerg DH, Conley Y. Association between serotonin transport polymorphisms and postdischarge nausea and vomiting in women following breast cancer surgery. Oncol Nurs Forum. 2014 Mar 1;41(2):195-202. doi: 10.1188/14.ONF.195-202.</citation>
    <PMID>24578078</PMID>
  </results_reference>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>August 9, 2018</study_first_submitted>
  <study_first_submitted_qc>August 10, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 13, 2018</study_first_posted>
  <last_update_submitted>May 18, 2020</last_update_submitted>
  <last_update_submitted_qc>May 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nausea</mesh_term>
    <mesh_term>Vomiting</mesh_term>
    <mesh_term>Postoperative Nausea and Vomiting</mesh_term>
    <mesh_term>Disease Susceptibility</mesh_term>
    <mesh_term>Genetic Predisposition to Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>The researchers make a plan to share informations via Red Cap</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

